Evidence map›Paper›PMID 26207060›Full record

ArticleDiabetes care2015

Prevalence and Regional Distribution of Autoantibodies Against GAD65Ab in a European Population Without Diabetes: The EPIC-InterAct Study.

Olov Rolandsson, Christiane S Hampe, Patrik Wennberg, Jared Radtke, Claudia Langenberg, Nicholas Wareham, EPIC-InterAct Study Group

Abstract readLetter
In one paragraph

Article in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olov RolandssonDivision of Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden olov.rolandsson@umu.se.
Christiane S HampeDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Patrik WennbergDivision of Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Jared RadtkeDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Claudia LangenbergMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, U.K.
Nicholas WarehamMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, U.K.
EPIC-InterAct Study Group

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
ISLET CELL MEMBRANE ANTIBODIES IN DIABTESR01DK026190 · NIDDK · UNIVERSITY OF WASHINGTON · PI HAMPE, CHRISTIANE S · 1986 to 2016
$4.9M
Medical Research Council MC_U106179471Medical Research Council MC_UU_12015/1NIDDK NIH HHS DK017047NIDDK NIH HHS DK26190NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK026190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26207060
PMCPMC4512134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.